These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24707983)

  • 1. Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.
    Ashare RL; Schmidt HD
    Expert Opin Drug Discov; 2014 Jun; 9(6):579-94. PubMed ID: 24707983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
    Perkins KA; Broge M; Gerlach D; Sanders M; Grobe JE; Cherry C; Wilson AS
    Health Psychol; 2002 Jul; 21(4):332-9. PubMed ID: 12090675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distress tolerance and early smoking lapse.
    Brown RA; Lejuez CW; Kahler CW; Strong DR; Zvolensky MJ
    Clin Psychol Rev; 2005 Sep; 25(6):713-33. PubMed ID: 16023275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.
    Evans DE; Sutton SK; Jentink KG; Lin HY; Park JY; Drobes DJ
    Genes Brain Behav; 2016 Sep; 15(7):621-6. PubMed ID: 27453054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.
    Herman RJ; Schmidt HD
    Physiol Behav; 2024 Jul; 281():114565. PubMed ID: 38663460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice.
    Saravia R; Ten-Blanco M; Grande MT; Maldonado R; Berrendero F
    Brain Behav Immun; 2019 Jan; 75():228-239. PubMed ID: 30391635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
    Liechti ME; Markou A
    CNS Drugs; 2008; 22(9):705-24. PubMed ID: 18698872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
    Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
    Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicotine withdrawal on cognition in a clinical trial setting.
    Wesnes KA; Edgar CJ; Kezic I; Salih HM; de Boer P
    Psychopharmacology (Berl); 2013 Sep; 229(1):133-40. PubMed ID: 23591603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does smoking cue-induced craving tell us anything important about nicotine dependence?
    Perkins KA
    Addiction; 2009 Oct; 104(10):1610-6. PubMed ID: 19426293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.
    Herman AI; Waters AJ; McKee SA; Sofuoglu M
    Psychopharmacology (Berl); 2012 Apr; 220(3):611-7. PubMed ID: 21947318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
    Dawkins L; Turner J; Hasna S; Soar K
    Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
    Gold MS; Herkov MJ
    J Addict Dis; 1998; 17(1):7-21. PubMed ID: 9549599
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
    Shiffman S; Ferguson SG; Gwaltney CJ; Balabanis MH; Shadel WG
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):637-44. PubMed ID: 16261317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Research on Nicotine Dependence.
    Falcone M; Lee B; Lerman C; Blendy JA
    Curr Top Behav Neurosci; 2016; 28():121-50. PubMed ID: 26873019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can brain games help smokers quit?: Results of a randomized clinical trial.
    Loughead J; Falcone M; Wileyto EP; Albelda B; Audrain-McGovern J; Cao W; Kurtz MM; Gur RC; Lerman C
    Drug Alcohol Depend; 2016 Nov; 168():112-118. PubMed ID: 27635998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of social stress during acute nicotine abstinence.
    Wardle MC; Munafò MR; de Wit H
    Psychopharmacology (Berl); 2011 Nov; 218(1):39-48. PubMed ID: 21234550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nicotine addiction: present therapeutic options and pipeline developments.
    Polosa R; Benowitz NL
    Trends Pharmacol Sci; 2011 May; 32(5):281-9. PubMed ID: 21256603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.